# MRK PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/MRK
Company: Merck

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with MRK.

## MRK PDUFA Milestones

- 2026-06-19 — PDUFA — Welireg/Belzutifan (MK-6482) + Keytruda/Pembrolizumab (MK-3475) (HIF-2α/PD-1 Blockade) treating Adjuvant Clear Cell Renal Cell Carcinoma After Nephrectomy
  Company: Merck
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/june (June 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/MRK
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the MRK PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with MRK, including decision dates, application stage, and summary details when available.
### Where can I find more context for MRK?

Use the BioPharmSignal company page for MRK to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.